ORGANOGENESIS INC.

Lobbying for ORGANOGENESIS INC.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $300,000.00 expenses · posted Jan 19, 2026

Lobbying activity 3

Medicare/Medicaid

Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products

Health Issues

FDA policy on chronic wound healing products

Manufacturing

Discussion around new company manufacturing facilities located in Smithfield, Rhode Island.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.